TMCnet News
Research and Markets: Xerosis (Dry Skin) - Pipeline Review, H1 2014: 3 Companies and 6 Drugs ProfiledDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/qnqlsk/xerosis_dry) has announced the addition of the "Xerosis (Dry Skin) - Pipeline Review, H1 2014" report to their offering. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved:
Drug Profiles:
For more information visit http://www.researchandmarkets.com/research/qnqlsk/xerosis_dry About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
